 | • レポートコード：TPM-B04419 • 出版社/出版日：Transparency Market Research / 2018年2月 • レポート形態：英文、PDF、244ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、馬向け健康管理の世界市場について調べ、馬向け健康管理の世界規模、市場動向、市場環境、製品種類別分析、病型別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・馬向け健康管理の世界市場動向 ・馬向け健康管理の世界市場環境 ・馬向け健康管理のバリューチェーン分析 ・馬向け健康管理の世界市場規模 ・馬向け健康管理の世界市場規模：製品種類別 ・馬向け健康管理の世界市場規模：病型別 ・馬向け健康管理の世界市場規模：流通経路別 ・馬向け健康管理の世界市場：地域別市場規模・分析 ・馬向け健康管理の北米市場規模・予測 ・馬向け健康管理のアメリカ市場規模・予測 ・馬向け健康管理の中南米市場規模・予測 ・馬向け健康管理のヨーロッパ市場規模・予測 ・馬向け健康管理のアジア市場規模・予測 ・馬向け健康管理の日本市場規模・予測 ・馬向け健康管理の中国市場規模・予測 ・馬向け健康管理のインド市場規模・予測 ・馬向け健康管理の中東市場規模・予測 ・馬向け健康管理のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Equine Healthcare Market: Overview
This report provides in-depth region wise and country wise analysis of the equine healthcare market. Stakeholders of this report include manufacturers of veterinary products, industry practitioners, research professionals, and new players planning to enter the market.
The report provides qualitative and quantitative analysis of the global equine healthcare market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies, market size, and forecast for the global equine healthcare market in major countries. Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the equine healthcare market with information on leading segments and sub-segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.
The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global equine healthcare market. These factors would aid the stakeholders in establishing a strong foothold in the global equine healthcare market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the equine healthcare products. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.
Global Equine Healthcare Market: Segmentation
The equine healthcare market has been extensively analyzed on basis of the product type (drugs, vaccines and supplemental feed additives), disease type and distribution channel, and geography. The market by product type is further segmented as drugs, vaccines and supplemental feed additives. The drugs sub-segment is classified into anti-infectives, anti-inflmmatory, paracititidis and others whereas the vaccines sub-segment is categorized into inactivated, live attenuated, recombinant and others. Additionally, the supplemental feed additives type sub-segment is segmented into minerals, vitamins, proteins and amino acids, enzyme, others. The distribution channel segment has been classified into veterinary hospitals and clinics, retail pharmacies and drug stores and others. Furthermore, the market by disease type is classified into west nile virus, equine rabies, potomac horse fever, tetanus, equine influenza, equine herpes virus, equine encephalomyelitis, others.
By geography, the equine healthcare market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Spain, Italy, Japan, China, India, Australia and New Zealand, Brazil, Mexico, GCC (Gulf Cooperation Council) and South Africa have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the equine healthcare market in various regions have been provided in this section. This report also includes various ups and downs about particular country or geography that has impacted the overall market globally.
Global Equine Healthcare Market: Competitive Dynamics
The report provides a detailed outline/blueprint of the equine healthcare market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. Prominent key players are Bayer AG (Bayer Animal Health), Boehringer Ingelheim, Ceva Santé Animale , Eli Lilly and Company (Elanco) , EQUINE PRODUCTS UK LTD , Merck & Co. (Merck Animal Health), Sanofi (Merial), Purina Animal Nutrition LLC., Vetoquinol S.A. and Zoetis.
The global equine healthcare market is segmented as given below:
Global Equine Healthcare Market, by Product Type
Drugs
Anti-infectives
Anti-inflammatory
Parasiticides
Others
Vaccine
Inactivated
Live Attenuated
Recombinant
Others
Supplemental Feed additives
Proteins and amino acids
Vitamins
Enzymes
Minerals
Others
Global Equine Healthcare Market, by Disease Type
Equine Influenza
Equine Herpes virus
Equine Encephalomyelitis
West Nile Virus
Equine Rabies
Potomac Horse Fever
Tetanus
Others
Global Equine Healthcare Market, by Distribution Channel
Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores
Others
Global Equine Healthcare Market, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (MEA)
South Africa
GCC Countries
Rest of Middle East & Africa
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Research Highlights
1.3. Assumptions and Acronyms Used
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Market Overview
4.1. Market Segmentation
4.2. Industry Evolution/Developments
4.3. Overview: Global Equine Health Care Market Analysis, Revenue (US$ Mn) and Forecast
4.4. Market Dynamics
4.4.1. Drivers
4.4.1.1. The equine industry has strong impact on overall economy
4.4.1.2. High incidence of equine infections
4.4.1.3. Initiatives by equine health care organizations and market participants
4.4.2. Restrains
4.4.2.1. Decline in global equine population
4.4.3. Opportunities
4.4.3.1. Rise in demand for pet insurance
4.4.4. Supply-Demand Scenario of Equine Healthcare Market
4.4.5. Porter’s Five Forces Analysis
4.4.6. Value Chain Analysis
4.4.7. Animal Health Care Overview
4.4.8. Global Equine Disease Prevalence, 2016
4.4.9. Policies and Regulations
4.4.10. Success Stories of Top 3 Players
4.4.11. Key Decision Makers and Selection Criteria
4.4.12. Key Brand Analysis
4.4.13. Applied SWOT
Chapter 5. Global Equine Healthcare Market Analysis and Forecasts, By Product Type
5.1. Key Findings
5.2. Introduction
5.3. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
5.3.1. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
5.3.1.1. Anti-Infectives
5.3.1.2. Anti-Inflammatory
5.3.1.3. Parasiticides
5.3.1.4. Others
5.3.2. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
5.3.2.1. Inactivated
5.3.2.2. Live Attenuated
5.3.2.3. Recombinant
5.3.2.4. Others
5.3.3. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
5.3.3.1. Minerals
5.3.3.2. Vitamins
5.3.3.3. Proteins and Amino Acids
5.3.3.4. Enzymes
5.3.3.5. Others
5.4. Key Trends
Chapter 6. Global Equine healthcare Market Analysis, by Distribution Channel
6.1. Key Findings
6.2. Introduction
6.3. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
6.3.1. Veterinary Hospitals and Clinics
6.3.2. Retail Pharmacies and Drug Stores
6.3.3. Others
6.4. Key Trends
Chapter 7. Global Equine healthcare Market Analysis, by Disease Type
7.1. Key Findings
7.2. Introduction
7.3. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
7.3.1. West Nile Virus
7.3.2. Equine Rabies
7.3.3. Potomac Horse Fever
7.3.4. Tetanus
7.3.5. Equine Influenza
7.3.6. Equine Herpes Virus
7.3.7. Equine
7.4. Key Trends
Chapter 8. Global Equine healthcare Market Analysis, by Region
8.1. Geographical Scenario
8.2. Global Equine Healthcare Market Analysis, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Equine Healthcare Market: Regional Trends
Chapter 9. North America Equine healthcare Market Analysis
9.1. Key Findings
9.2. Overview: North America Equine Healthcare Market Revenue (US$) Forecast
9.3. Pricing Trend: North America Equine Healthcare Market
9.4. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Country
9.4.1. U.S.
9.4.2. Canada
9.5. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
9.6. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
9.7. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
9.8. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
9.9. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
9.10. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
9.11. Market Attractiveness Analysis
9.11.1. By Country
9.11.2. By Product Type
9.11.3. By Distribution Channel
9.11.4. By Disease Type
9.12. Key Trends
Chapter 10. Europe Equine healthcare Market Analysis
10.1. Key Findings
10.2. Overview: Europe Equine Healthcare Market Revenue (US$) Forecast
10.3. Pricing Trend: Europe Equine Healthcare Market
10.4. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Country
10.4.1. U.K.
10.4.2. France
10.4.3. Germany
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
10.6. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
10.7. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
10.8. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
10.9. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
10.10. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Product Type
10.11.3. By Distribution Channel
10.11.4. By Disease Type
10.12. Key Trends
Chapter 11. Asia Pacific Equine healthcare Market Analysis
11.1. Key Findings
11.2. Overview: Asia Pacific Equine Healthcare Market Revenue (US$) Forecast
11.3. Pricing Trend: Asia Pacific Equine Healthcare Market
11.4. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Country
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia and New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
11.6. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
11.7. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
11.8. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
11.9. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
11.10. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
11.11. Market Attractiveness Analysis
11.11.1. By Country
11.11.2. By Product Type
11.11.3. By Distribution Channel
11.11.4. By Disease Type
11.12. Key Trends
Chapter 12. Latin America Equine healthcare Market Analysis
12.1. Key Findings
12.2. Overview: Latin America Equine Healthcare Market Revenue (US$) Forecast
12.3. Pricing Trend: Latin America Equine Healthcare Market
12.4. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Country
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
12.6. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
12.7. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
12.8. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
12.9. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
12.10. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
12.11. Market Attractiveness Analysis
12.11.1. By Country
12.11.2. By Product Type
12.11.3. By Distribution Channel
12.11.4. By Disease Type
12.12. Key Trends
Chapter 13. Middle East & Africa Equine healthcare Market Analysis
13.1. Key Findings
13.2. Overview: Middle East & Africa Equine Healthcare Market Revenue (US$) Forecast
13.3. Pricing Trend: Middle East & Africa Equine Healthcare Market
13.4. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Country
13.4.1. GCC
13.4.2. South Africa
13.4.3. Rest of Middle East and Africa
13.5. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
13.6. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
13.7. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
13.8. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
13.9. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
13.10. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
13.11. Market Attractiveness Analysis
13.11.1. By Country
13.11.2. By Product Type
13.11.3. By Distribution Channel
13.11.4. By Disease Type
13.12. Key Trends
Chapter 14. Competition Landscape
14.1. Competition Matrix
14.2. Market Share Analysis
14.3. Company Profiles
14.3.1. Bayer AG (Bayer Animal Health)
14.3.1.1. Company Details
14.3.1.2. Company Description
14.3.1.3. Business Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Financial Analysis
14.3.1.6. Strategic Overview
14.3.2. Boehringer Ingelheim
14.3.2.1. Company Details
14.3.2.2. Company Description
14.3.2.3. Business Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Financial Analysis
14.3.2.6. Strategic Overview
14.3.3. Ceva Santé Animale
14.3.3.1. Company Details
14.3.3.2. Company Description
14.3.3.3. Business Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Financial Analysis
14.3.3.6. Strategic Overview
14.3.4. Eli Lilly and Company (Elanco)
14.3.4.1. Company Details
14.3.4.2. Company Description
14.3.4.3. Business Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Financial Analysis
14.3.4.6. Strategic Overview
14.3.5. EQUINE PRODUCTS U.K. LTD
14.3.5.1. Company Details
14.3.5.2. Company Description
14.3.5.3. Business Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Financial Analysis
14.3.5.6. Strategic Overview
14.3.6. Merck & Co. (Merck Animal Health)
14.3.6.1. Company Details
14.3.6.2. Company Description
14.3.6.3. Business Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Financial Analysis
14.3.6.6. Strategic Overview
14.3.7. Sanofi (Merial)
14.3.7.1. Company Details
14.3.7.2. Company Description
14.3.7.3. Business Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Financial Analysis
14.3.7.6. Strategic Overview
14.3.8. Purina Animal Nutrition LLC
14.3.8.1. Company Details
14.3.8.2. Company Description
14.3.8.3. Business Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Financial Analysis
14.3.8.6. Strategic Overview
14.3.9. Vetoquinol S.A.
14.3.9.1. Company Details
14.3.9.2. Company Description
14.3.9.3. Business Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Financial Analysis
14.3.9.6. Strategic Overview
14.3.10. Zoetis
14.3.10.1. Company Details
14.3.10.2. Company Description
14.3.10.3. Business Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Financial Analysis
14.3.10.6. Strategic Overview
Table 01: Global Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 03: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 04: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives Type, 2015–2025
Table 05: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 06: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 07: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Equine Healthcare Market, Product Pricing (USS) Analysis, 2015–2025
Table 09: North America Equine Healthcare Market (US$ Mn) Forecast, by Country, 2015–2025
Table 10: North America Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015–2025
Table 11: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 12: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 13: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additive Type, 2015–2025
Table 14: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 15: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 16: Europe Equine Healthcare Market, Product Pricing (US$) Analysis, 2015–2025
Table 17: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Country/, 2015–2025
Table 18: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 19: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 20: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 21: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives, 2015–2025
Table 22: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 23: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 24: Asia Pacific Equine Healthcare Market, Product Pricing (US$) Analysis, 2015–2025
Table 25: Asia Pacific Equine Healthcare Market (US$ Mn) Forecast, by Country/, 2015–2025
Table 26: Asia Pacific Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015–2025
Table 27: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 28: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 29: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives Type, 2015–2025
Table 30: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 31: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 32: Latin America Equine Healthcare Market, Product Pricing (US$) Analysis, 2015–2025
Table 33: Latin America Equine Healthcare Market (US$ Mn) Forecast, by Country, 2015–2025
Table 34: Latin America Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015–2025
Table 35: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 36: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 37: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives Type, 2015–2025
Table 38: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 39: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 40: Middle East & Africa Equine Healthcare Market, Product Pricing (US$) Analysis, 2015–2025
Table 41: Middle East & Africa Equine Healthcare Market (US$ Mn) Forecast, by Country, 2015–2025
Table 42: Middle East & Africa Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015–2025
Table 43: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 44: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 45: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives Type, 2015–2025
Table 46: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 47: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025